For IL-17A, its expression was positively correlated with the T dysfunction value in LAML (GSE12417_GPL570) and melanoma (TCGA), and negatively correlated with the T dysfunction value in BRCA (METABRIC) and UCEC (TCGA); its expression was positively correlated with TIDE value in BRCA (r = 0.10, p < 0.001), CESC (r = 0.27, p < 0.001), DLBC (r = 0.39, p < 0.01), HNSC (r = 0.19, p < 0.001), PRAD (r = 0.21, p < 0.001), and THCA (r = 0.30, p < 0.001). This evidence concerns the gene IL17A and melanoma.